CAS: 338-95-4; (8S,9R,10S,11S,13S,14S,17R)-9-Fluoro-11,17-Dihydroxy-17-(2-Hydroxyacetyl)-10,13-Dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-Dodecahydro-3H-Cyclopenta[a]Phenanthren-3-One (Prednisolone Impurity)

该化合物是一种合成的花生类固醇,具有抗炎和免疫抑制特性,其特点是能够调节免疫反应和减少炎症,使其在各种治疗应用中有用,特别是在治疗过敏,哮喘和自体免疫紊乱等条件下有用;硅红素通常以药物配方施用,通常作为一种注射剂或时事剂;其行动机制涉及对凝糖素受体的约束,导致对基因表达方式的调节,最终减少亲炎细胞素的生产;该物质因其威力和相对较低的矿物类活动而著称,这种物质尽量减少液体留存和通常与皮质科植物相关的其他副作用;Isolupredone的药理科动物,包括吸收,分配,新陈代谢和排泄,受到其化学结构的影响,这种结构允许在管理潜在不利影响时有效使用治疗.同所有可口服类固化剂一样,仔细考虑与服用剂量相关的基本风险和治疗时间长短是同基本治疗相联的.

结构式图片

上下游产品

CAS号338-98-7 醋酸异氟泼尼松 | CAS号514-36-3 醋酸氟氢可的松 | CAS号52-21-1 醋酸泼尼松龙 | CAS号4380-55-6 pregna-1,4,9(11... | CAS号4224-31-1 9α-Brom-11β,17α... | CAS号38680-83-0 醋酸泼尼松龙环氧 | CAS号127-31-1 氟氢可的松 | CAS号338-98-7 醋酸异氟泼尼松 | CAS号1250-85-7 21-乙酰氧基-9-氟-11-... | CAS号124-94-7 曲安西龙

合成工艺路线路线简述

    📜醋酸氟氢可的松置于didymella Lycopersicin体系中,化学反应生成异氟泼尼松
    参考文献:Herstellung Weiterer 1-Dehydro-Steroide Auf Mikrobiologischem Wege.7岁的mikrobiologische Reaktionen
    标题:Herstellung Weiterer 1-Dehydro-Steroide Auf Mikrobiologischem Wege.7岁的mikrobiologische Reaktionen
    摘要:检测蔓该属的某些真菌特别适合于酶引入1,2-双键进δ 4-3-酮-类固醇.以这种方式,已经制备了许多新的1-脱氢类固醇.
    Doi:10.1002/hlca.19550380623

    海关参考信息

    专利信息


    专利号:US-2024082118-A1
    优先权日:2021-05-19
    标 题:Topical compositions and methods of preparing the same
    发明人:ABRAMOVICH SAGI; AVIDOR GAL; LANDA BENZION
    权利人:LANDA LABS 2012 LTD
    摘要:There is disclosed a composition comprising a water-insoluble thermoplastic compound capable of stimulating collagen synthesis (CSSC), the CSSC having a molecular weight of more than 0.6 kDa and being dispersed in a polar carrier as nano-elements having an average diameter of 200 nm or less and a viscosity of 107 mPa·s or less. The nano-elements of CSSC can be capable of stimulating the synthesis of skin proteins and/or enabling the delivery of active agents upon their application to a surface to be treated therewith. Methods for preparing the compositions and uses thereof are also provided.

    专利号:US-2024287041-A1
    优先权日:2021-05-20
    标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
    发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

    专利号:US-9994558-B2
    优先权日:2013-09-20
    标题 :Multicyclic compounds and methods of using same
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).

    专利号:WO-2022246227-A1
    优先权日:2021-05-20
    标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

    专利号:US-2025144039-A1
    优先权日:2022-07-13
    标题:Compositions comprising surface modified globular nano-particles
    发明人:ABRAMOVICH SAGI; AVIDOR GAL; LANDA BENZION
    权利人:LANDA LABS 2012 LTD
    摘要:There are disclosed compositions comprising core-shell nano-elements composed in their core of a water-insoluble thermoplastic compound having a molecular weight of more than 0.6 kDa and in their shell of at least one fatty amine, or a part thereof, the core-shell nano-elements having a viscosity of 107 mPa·s or less and being dispersed in a polar carrier as nano-elements having an average diameter of 200 nm or less. The water-insoluble thermoplastic compound can be capable of stimulating the synthesis of skin proteins and/or enabling the delivery of active agents upon application of the core-shell nano-elements to a surface to be treated therewith. Methods for preparing the composition and uses thereof are also provided.

    专利号:US-10363247-B2
    优先权日:2015-08-18
    标 题:(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to substituted benzofuranyl compounds and, more particularly, to a compound represented by Structural Formula 1a: (I) or a pharmaceutically acceptable salt thereof. The invention also includes the synthesis and use of the compound of Structural Formula 1a, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of diseases or disorder selected from cancer (e.g., lymphoma, such as mantle cell lymphoma), a neurodegenerative disease, an inflammatory diseases or an immune system disease (e.g., a T-Cell mediated autoimmune disease) in a subject in need thereof. The method comprises administering to a subject in need thereof a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof, or a composition comprising a compound of the invention, or a pharmaceutically acceptable salt thereof.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198
    摘要:ROCCAVILLA G, CARBONARA P. [The effect of 9-alpha-fluoroprednisolone on the rat thyroid]. Riv Patol Clin. 1958 Aug;13(8):328–31.
    摘要:CARBONARA P, ROCCAVILLA G. [9-alpha-fluoroprednisolone in hepatic regeneration]. Riv Patol Clin. 1958 Sep;13(9):333–48.
    摘要:VILLA L, BALLABIO CB, SALA G. [Clinical & metabolic effect of 16 alpha-methyl-9 alpha-fluoroprednisolone or dexamethasone]. Reumatismo. 1958 May;10(3):127–33.
    参考文献:10.1136/ard.17.4.376
    摘要:BOLAND EW. Clinical observations with 16 alpha-methyl corticosteroid compounds; preliminary therapeutic trials with dexamethasone (16 alpha-methyl 9 alpha-fluoroprednisolone) in patients with rheumatoid arthritis. Ann Rheum Dis. 1958 Dec;17(4):376–82.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知